Bayer AG
0
0
0%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 9.7B 10.7B 13.7B 11.7B
Cost of revenue 4.3B 4.4B 5.6B 5.7B
Gross profit 5.4B 6.4B 8.1B 6.0B
Operating expense
Research & development 1.5B 1.4B 1.5B 1.7B
Selling general and admin 3.4B 3.5B 3.7B 4.3B
Other operating expenses 1.3B 2.1B 829M -3.9B
Operating income -543M 13M 2.3B 3.5B
Non operating interest income
Income 130M 92M 114M
Expense 762M 390M 473M 385M
Other income expense
Pretax income -1.2B -426M 1.8B -481M
Tax provision -202M -236M 526M -153M
Net income -959M -190M 1.3B -328M
Basic EPS -1.0 -0.2 1.3
Diluted EPS -1.0 -0.2 1.3
Basic average shares 982.4M 982.4M 982.4M
Diluted average shares 982.4M 982.4M 982.4M
EBITDA 606M 236M 3.5B 1.7B
Net income from continuing op. -959M -190M 1.3B -328M
Minority interests -4M -9M -5M -7M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 3 hours 9 minutes

14:25
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).